Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole versus vonoprazan in non-bismuth quadruple therapy for Helicobacter pylori eradication
PACTR202410526786105Phase 4Recruiting
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of omeprazole and vonoprazan in Helicobacter pylori infection (2 arms), sponsored by None. Primary endpoint: Eradication rate in each group. Started Oct 2024; status: recruiting.
02
Drugs
omeprazolevonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202410526786105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202410526786105.